KPLPharmaceuticals
Kwality Pharmaceuticals Ltd — PE Ratio & Valuation Analysis
₹1306.35
-4.50%
Current P/E19.53xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E33.5x41.7% below avg
✅
38.5% Discount to Industry
KPL P/E 19.53x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹38.36 | ₹1108 | 28.9x |
| 2024 | ₹22.76 | ₹867 | 38.1x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Kwality Pharmaceuticals Ltd Valuation
Kwality Pharmaceuticals Ltd (KPL) currently trades at 19.53x earnings. The Pharmaceuticals sector average PE is 31.77x. KPL is trading at a discount to peers — may indicate relative value. Historically, KPL has traded at an average PE of 33.5x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
16.31%
Dividend Yield
0.00%
More on Kwality Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.